Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults

NCT: NCT06216132 · COMPLETED

NCT IDNCT06216132
StatusCOMPLETED
Start Date2024-06-24
Completion2025-04-25

Brief Summary

The purpose of this study is to evaluate the safety and blood levels of a medicine, naltrexone, contained within an implant in healthy volunteers age 18 to 65 years. To do this, the implant containing the drug will be inserted under the skin, left in place for 3 months and then removed.

Frequently Asked Questions

What is Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults?

Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults is a clinical trial registered under NCT06216132. Current status: COMPLETED.

What is the status of NCT06216132?

The current status of NCT06216132 (Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults) is: COMPLETED.

When did Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults start?

Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults started on 2024-06-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑